Understanding the Risks of Semaglutide: What You Need to KnowSemaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has acquired considerable attention recently due to its effectiveness in handling type 2 diabetes and obesity. While its benefits are well-documented, it's essential for clients and healthcare companies to be aware of the prospective
